State govt solved long-pending problems of doctors: Bharath
Speaking at the inauguration of the Medical Council's registration unit at the Kurnool Medical College Complex on Saturday, the minister said the new facility will allow doctors to complete essential registration services within the district itself, eliminating the need to travel to Vijayawada.
Bharath stated that this initiative is part of the government's broader vision under Chief Minister N Chandrababu Naidu and minister Nara Lokesh to offer citizen-centric, decentralised governance. The state has already introduced a WhatsApp-based governance model offering over 500 services. Previously, doctors had to endure significant time and financial burdens to visit Vijayawada for certificate renewal and registration — an ordeal especially challenging for senior doctors above the age of 60.
With the new district-level unit, these hurdles have been removed, making the process more accessible and efficient. The minister also requested the Medical Council to extend similar services to dental practitioners.
Addressing the gathering, AP Medical Council chairman Dr Daggumati Srihari Rao said that the council will now provide re-registration and renewal services every Saturday and Sunday at the district level. He added that the registration fee, previously ranging from Rs 40,000 to Rs 50,000, has been significantly reduced now to Rs 6,000 for doctors above 75 years and Rs 8,000 for others. Doctors can also renew their certificates online if they have completed the biometric verification process, and the renewal window opens three months prior to the expiry of the existing registration.
Adoni MLA Dr Parthasarathi appreciated the initiative, noting that many doctors have been practising without timely renewals, putting their professional credibility at risk. With local facilities now available, he urged all medical professionals to take advantage of the opportunity.
Kurnool Government General Hospital superintendent Dr Venkateswarlu and Medical College principal Dr Chitti Narsamma also expressed gratitude to the state government and the Medical Council, recognising the convenience this move brings to the medical community. Faculty members from the college were also present at the event.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Union Health Minister JP Nadda, Delhi CM Rekha Gupta flag off Ayushman Bharat registration vans in New Delhi
New Delhi: Union Minister of Health and Family Welfare JP Nadda and Delhi Chief Minister Rekha Gupta flagged off Ayushman Bharat registration vans in Vigyan Bhavan in New Delhi on Sunday. Addressing the event, the BJP chief slammed the Aam Aadmi Party (AAP) for not using Rs 1700 crore under the Ayushman Bharat Scheme for public welfare. He said, "Under PM-Ayushman Bharat Health Infrastructure Mission, we had given Rs 1700 crore to Delhi between 2021 to February 2025, but not one penny was spent, and now the responsibility of the expenditure of this fund for the public welfare has fallen on the shoulders of (Delhi CM) Rekha ji." Continuing his attack against AAP, he added, "We were ready to quench Delhi's thirst with water, but you kept the vessel upside down, so what could be done? On February 20, you turned up the vessel, so you got Ayushman Bharat. Prime Minister Narendra Modi was ready to provide Rs 5 lakh for the poor's healthcare since September 2, 2017. Their pride came in between. They did injustice to the poor." Lauding Ayushman Arogya Mandir , Nadda targeted Aam Aadmi Mohalla Clinic and called AAP shortsighted. "A wise man is farsighted and thinks of Ayushman Arogya Mandir, and shortsighted ones bring Mohalla Clinics. From the time a mother conceives a child to the time the child turns two, Ayushman Arogya Mandir takes care of all the vaccinations. India is playing a lead role in reproductive and child health care," JP Nadda said. Last month, on June 17, Delhi Chief Minister Rekha Gupta and Ministers Parvesh Verma and Manjinder Singh Sirsa inaugurated Ayushman Arogya Mandirs in the national capital. After the inauguration, Manjinder Singh Sirsa informed that 33 Ayushman Aarogya Mandirs were inaugurated with excellent infrastructure and facilities. "A total of 33 Arogya Mandirs have been inaugurated today, and they have excellent infrastructure", Manjinder Singh Sirsa said. Meanwhile on May 18, in a major boost to healthcare under the Pradhan Mantri Vay Vandana Yojana , Delhi Minister Ashish Sood distributed Ayushman Bharat cards to senior citizens aged 70 and above in Janakpuri, West Delhi.
Time of India
2 hours ago
- Time of India
Himachal: AIIMS Bilaspur sets target to make state self-reliant in healthcare
Bilaspur: The All India Institute of Medical Science (AIIMS) Bilaspur is all set to make Himachal Pradesh a self-reliant state in health care. The AIIMS Bilaspur Director, Prof DN Sharma, shared significant milestones of the institute's progress with the media on Sunday, highlighting rapid infrastructure expansion, medical breakthroughs, and a focused drive toward cancer research and trauma care. In just less than three years since its inception, AIIMS Bilaspur has increased its inpatient capacity from 690 to 728 beds, catering to over 1,500 patients daily, with more than 4,000 indoor admissions every month. The institute also recorded its first successful kidney transplant, a major achievement in its clinical journey. Over 30,000 patients are being treated monthly, and the hospital has developed a strong community outreach programme, backed by interdisciplinary collaborations and state-of-the-art equipment, including an MRI facility. AIIMS Bilaspur is equipped with four times more ventilators than other hospitals in Himachal Pradesh, ensuring robust emergency preparedness. With a strong academic backbone, the institute now has 620 students, including 100 MBBS seats, and offers 17 broad specialities. However, Prof. Sharma noted that some faculty positions in medical gastroenterology remain vacant, though recruitment drives are ongoing. Cancer care remains a major focus area, with work underway for a dedicated Trauma Centre, and a proposal for Phase 2 expansion valued at Rs 178.05 crore. A feasibility survey for Rs 332 crore has also been conducted to support future developments, including enhanced cancer treatment infrastructure. AIIMS Bilaspur is also actively participating in ICMR-backed research projects on breast and cervical cancer and has seen high utilisation in its radiation oncology department, treating 83 patients regularly, with daily attendance ranging from 20 to 30 patients, nearing 900 total so far. Prof Sharma emphasised lifestyle-related cancers and rising cases such as lung cancer, along with Delhi topping the chart for prostate cancer prevalence. AIIMS Bilaspur is also expected to soon be equipped with PET scan and titration control facilities to enhance diagnostic precision. AIIMS Bilaspur is now among the fastest-growing AIIMS in the country, both in terms of infrastructure and services and aims to ensure that people in the region no longer need to travel outside Himachal Pradesh for advanced treatment. (ANI)
Business Standard
2 hours ago
- Business Standard
Biocon gets MHRA UK approval for marketing Denosumab biosimilars 'Vevzuo' & 'Evfraxy'
Biocon said that Biocon Biologics has received marketing authorisations from UK Medicines and Healthcare products Regulatory Agency for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is authorized for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with advanced malignancies involving bone. Vevzuo is also authorized for the treatment of adults and skeletally mature adolescents with giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity. Evfraxy is authorized for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women this significantly reduces the risk of vertebral, non-vertebral, and hip fractures. Furthermore, Evfraxy is authorized for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. In men with prostate cancer receiving hormone ablation, this significantly reduces the risk of vertebral fractures. Evfraxy is also authorized for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture. Clinical data showed that both Denosumab biosimilars have comparable safety and efficacy to the reference product. In Europe, the European Commission (EC) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their commercialization in all European Union (EU) member states and the European Economic Area (EEA). Biocon is a global biopharma company dedicated to improving affordable access to therapies for chronic conditions like diabetes, cancer, and autoimmune diseases. The companys consolidated net profit surged 154.2% to Rs 344.50 crore on a 12.8% jump in net sales to Rs 4,358.10 crore in Q4 FY25 over Q4 FY24. The scrip fell 1.29% to currently trade at Rs 375.25 on the BSE.
